Skin conditions and diseases are very common and affect millions of people each year, from acne and rosacea to eczema (also known as atopic dermatitis) and psoriasis. Acne, one of the most common skin ...

Do you or your child have areas of itchy, red, dry patches that get worse when you scratch? Chances are, one of you is among the millions of Americans who suffer from eczema. The word "eczema" can be ...

While eczema is a common skin condition, it can manifest in many different ways. And with so much possible variation, it's not always easy to properly identify eczema. Eczema symptoms can be mild — a ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. According to the Mayo Clinic, diaper rash and eczema are among ...

When searching for answers, expert advice matters. Here’s what dermatologists recommend to help caregivers confidently manage moderate to severe eczema in kids.

It’s itchy, irritating and very common. But if eczema is left unchecked, it can become a big problem. Credit...Edmon de Haro Supported by By Hallie Levine This guide was originally published on Jan.

Any diagnosis can affect romantic relationships, and atopic dermatitis is no exception. Here's how to communicate with your partner about the emotional aspects of living with eczema, balancing life's ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. Fortunately, most baby skin problems aren’t serious, and ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

SINGAPORE, Nov. 25, 2025 /PRNewswire/ -- A new ground-up survey "The Unseen Itch: How Eczema Disrupts Daily Life in Singapore" by Medical Channel Asia has uncovered a stark and often overlooked ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel ...